BNP Paribas Asset Management
AGN

BNP Paribas Asset Management’s Allergan plc AGN Stock Holding History

BNP Paribas Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-103,013
Closed -$18.2M – 860
2020
Q1 		$18.2M Buy
103,013
+599
+0.6% +$113K 0.16% 178
2019
Q4 		$19.6M Buy
102,414
+500
+0.5% +$90.2K 0.13% 207
2019
Q3 		$17.2M Buy
101,914
+4,607
+5% +$751K 0.13% 206
2019
Q2 		$16.3M Sell
97,307
-245,610
-72% -$34M 0.13% 210
2019
Q1 		$50.2M Buy
342,917
+63,679
+23% +$9.23M 0.42% 49
2018
Q4 		$37.1M Sell
279,238
-131,794
-32% -$21.6M 0.34% 65
2018
Q3 		$78.3M Buy
411,032
+98,312
+31% +$18.1M 0.6% 22
2018
Q2 		$52.1M Sell
312,720
-44,416
-12% -$7.13M 0.44% 35
2018
Q1 		$60.1M Sell
357,136
-9,138
-2% -$1.53M 0.51% 27
2017
Q4 		$59.9M Sell
366,274
-34,801
-9% -$6.25M 0.51% 26
2017
Q3 		$82.2M Buy
401,075
+62,199
+18% +$14.5M 0.7% 17
2017
Q2 		$82.4M Buy
338,876
+6,006
+2% +$1.41M 0.73% 17
2017
Q1 		$79.5M Sell
332,870
-2,974
-0.9% -$693K 0.73% 18
2016
Q4 		$70.5M Buy
335,844
+31,997
+11% +$6.63M 0.68% 19
2016
Q3 		$70M Buy
303,847
+13,888
+5% +$3.39M 0.6% 25
2016
Q2 		$67M Buy
289,959
+39,712
+16% +$9.16M 0.57% 29
2016
Q1 		$67.1M Sell
250,247
-42,441
-15% -$12.1M 0.57% 28
2015
Q4 		$91.5M Sell
292,688
-74,255
-20% -$22.1M 0.78% 16
2015
Q3 		$99.7M Sell
366,943
-63,886
-15% -$19.6M 0.87% 8
2015
Q2 		$131M Buy
430,829
+114,593
+36% +$34.2M 1.06% 5
2015
Q1 		$94.1M Buy
316,236
+43,486
+16% +$12.4M 0.72% 14
2014
Q4 		$70.2M Buy
272,750
+12,417
+5% +$3.1M 0.57% 31
2014
Q3 		$62.8M Buy
260,333
+10,797
+4% +$2.42M 0.51% 41
2014
Q2 		$55.7M Sell
249,536
-61,681
-20% -$12.8M 0.43% 54
2014
Q1 		$64.1M Buy
311,217
+39,685
+15% +$7.86M 0.49% 48
2013
Q4 		$45.6M Buy
271,532
+234,744
+638% +$36.7M 0.34% 88
2013
Q3 		$5.3M Sell
36,788
-997
-3% -$133K 0.04% 363
2013
Q2 		$4.77M Buy
+37,785
New +$4.28M 0.04% 413

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

BNP Paribas Asset Management's AGN Position: Q2 2020 in Review

BNP Paribas Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 103,013 shares — an estimated $18.2M sold.

BNP Paribas Asset Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $131M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • BNP Paribas Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • BNP Paribas Asset Management sold 103,013 Allergan plc shares in Q2 2020, an estimated $18.2M.
  • BNP Paribas Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • BNP Paribas Asset Management's Allergan plc position peaked at $131M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on BNP Paribas Asset Management's 13F filing for Q2 2020, filed 4 Aug 2020.